Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Brook
I
I
Armed Forces Radiobiology Research Institute, Bethesda, Maryland, USA.
D000038:Abscess / Q000382:microbiology / Q000517:prevention & control*; D000667:Ampicillin / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001442:Bacteroides Infections / Q000517:prevention & control; D001441:Bacteroides fragilis / Q000187:drug effects; D015313:Cefotetan / Q000627:therapeutic use*; D002440:Cefoxitin / Q000627:therapeutic use*; D002513:Cephamycins / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000517:prevention & control; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008826:Microbial Sensitivity Tests; D010406:Penicillins / Q000494:pharmacology; D010532:Peritoneal Diseases / Q000382:microbiology / Q000517:prevention & control*; D013407:Sulbactam / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D002513:Cephamycins; D010406:Penicillins; D015313:Cefotetan; D002440:Cefoxitin; D000667:Ampicillin; D013407:Sulbactam